Acadians are driven to break through barriers, to innovate and to persevere – and we all thrive when we have the right support. For #WomensEqualityDay, Jennifer Lichtman reflects on our company’s commitment to cultivating an inclusive workplace and the vital role our Women@Work Employee Resource Group takes in advocating and empowering women in the workplace.
Acadia Pharmaceuticals Inc.
Pharmaceutical Manufacturing
San Diego, California 75,575 followers
Acadia is trailblazing breakthroughs in neuroscience to elevate life.
Über uns
Our Acadia family of care-ageous warriors aspire to enable brighter moments for patients and their loved ones. For 30 years, we have been working at the forefront of healthcare to bring vital solutions to people who need them most. We developed and commercialized the first and only approved therapies for hallucinations and delusions associated with Parkinson’s disease psychosis and for the treatment of Rett syndrome. Our clinical-stage development efforts are focused on treating the negative symptoms of schizophrenia, Alzheimer’s disease psychosis and neuropsychiatric symptoms in central nervous system disorders. Important Notice for Candidates - Be Aware of Fraudulent Recruiting Activity Acadia Pharmaceuticals has become aware of fraudulent recruiting activity being circulated via email and LinkedIn by individuals impersonating Acadia Talent Acquisition employees. These communications may appear legitimate due to an official-looking Acadia email address or website, referencing of an actual recruiter and/or manager at Acadia (easily found on LinkedIn), and/or offer documents falsely signed by an Acadia executive. The impostor uses the incentive of a job interview and job offer to solicit sensitive personal information from the intended victim. Please note that the Acadia Talent Acquisition and HR Team will ONLY interact with a candidate from "Acadia-pharm.com" domain sourced emails. We do not request sensitive personal information, such as a Social Security Number, or payments of any kind during the interview or job offer process. Acadia strongly recommends individuals, who receive email solicitations, to carefully verify the authenticity of the correspondence before responding. Never provide personal information or click on links if you are unsure a communication’s legitimacy. If in doubt, please contact [email protected] to verify.
- Website
-
http://Acadia.com
External link for Acadia Pharmaceuticals Inc.
- Industrie
- Pharmaceutical Manufacturing
- Größe des Unternehmens
- 501-1,000 employees
- Hauptsitz
- San Diego, California
- Typ
- Öffentliches Unternehmen
- Gegründet
- 1993
Standorte
-
Primäre
12830 El Camino Real
Suite 400
San Diego, California 92130-3331, US
-
502 Carnegie Center
Suite 300
Princeton, New Jersey 08540, US
Employees at Acadia Pharmaceuticals Inc.
Aktualisierungen
-
When Ryan Reynolds lost his father, Jim Reynolds, to Parkinson's 10 years ago, it was devastating for him and his mother, Tammy. They learned that stigma often prevents families and individuals with Parkinson’s from speaking up about this common yet under-recognized aspect of the disease. This is why we are proud to partner with Ryan to raise awareness that there is #MoretoParkinsons than just motor symptoms. Learn more at MoretoParkinsons.com
-
-
Ryan Reynolds knows there is #MoretoParkinsons than just motor symptoms. At Acadia, we are proud to partner with Ryan Reynolds and his mom, Tammy, to raise awareness that hallucinations and delusions can be symptoms of Parkinson’s disease. Together, we can educate, reduce stigma, and encourage discussion. Find information and resources at https://lnkd.in/ehNFGaEH
More to Parkinson
-
Dive into Magnolia's latest fantastic adventure: dolphin swimming in Florida! Catch the latest episode now: https://lnkd.in/gCRuPCPr. #RettSyndrome #AdaptiveAdventures #AnimalAssistedTherapy
-
Today, we shared our Q2 2024 #earnings results. Read our financial summary and key updates here: bit.ly/3SDimIi.
-
-
We aim to foster an inclusive environment based on shared experiences, goals, and values, ensuring our #interns have valuable learning experiences and opportunities to grow. We're grateful for our partnership with Life Science Cares San Diego, which has introduced us to a talented group of individuals!
Our Project Onramp summer is in full swing! Check out these photos of some of our Acadia Pharmaceuticals Inc. interns at work! Thank you to their supervisors for making these students' experiences meaningful! Andrew Killinger, Nick C., Tonya C., Tessa Becker, Christopher Biwald, Melissa Chen, Tracy Arce, CSCP, Michele Silver, Kristen Hoskins, Rebecca Rice
-
-
We’re excited to be at the Alzheimer's Association® International Conference in Philadelphia this weekend. We look forward to connecting with the #alzheimers community while diving into a diverse scientific program dedicated to advancing dementia science and clinical practices. Learn more and register here: bit.ly/3pLO7no. #AAIC24
-
-
Today, we recognize the 34th anniversary of the Americans with Disabilities Act. We are committed to fostering an inclusive atmosphere and supporting this important law that protects the rights of people with disabilities, ensuring they have the same rights and opportunities as everyone else. #ADA34
-
-
Happy #NationalInternDay! Today, we recognize and appreciate our talented group of interns who bring creativity, enthusiasm, and fresh perspectives to our team. At Acadia, we are dedicated to fostering a culture of curiosity and belonging where we can bring our whole selves to work in our mission of elevating life.
-
-
This past week we were thrilled to have attended the Northwest Rett Syndrome Association Family Conference in Salem, Oregon. We were truly inspired by families, caregivers, and advocates who came together in support of #RettSyndrome.
-
Verbundene Seiten
Ähnliche Seiten
Jobs durchsuchen
Aktie
ACAD
NASDAQ
20 Minuten Verzögerung
$15.82
0.07 (0.444%)
- Öffnen Sie
- 15.77
- Niedrig
- 15.68
- Hoch
- 15.91
Daten von Refinitiv
Siehe mehr Informationen aufFinanzierung
Letzte Runde
Eigenkapital nach dem IPOUS$ 287.5M